Analysts predict that eMagin Co. (NYSE:EMAN) will report $6.30 million in sales for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for eMagin’s earnings, with estimates ranging from $5.60 million to $7.70 million. eMagin reported sales of $4.31 million in the same quarter last year, which indicates a positive year over year growth rate of 46.2%. The business is scheduled to issue its next earnings results on Friday, November 10th.

On average, analysts expect that eMagin will report full year sales of $6.30 million for the current year, with estimates ranging from $22.70 million to $28.50 million. For the next fiscal year, analysts expect that the firm will report sales of $31.64 million per share, with estimates ranging from $28.00 million to $34.00 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that cover eMagin.

eMagin (NYSE:EMAN) last released its earnings results on Thursday, August 10th. The semiconductor company reported ($0.07) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.05) by ($0.02). The company had revenue of $5.26 million for the quarter, compared to analyst estimates of $6.00 million. eMagin had a negative net margin of 43.16% and a negative return on equity of 44.28%.

EMAN has been the subject of a number of research analyst reports. HC Wainwright reaffirmed a “buy” rating and set a $4.00 price objective on shares of eMagin in a research report on Friday, September 15th. Rodman & Renshaw reissued a “buy” rating and set a $4.00 target price on shares of eMagin in a report on Friday, June 23rd. Finally, Zacks Investment Research downgraded eMagin from a “hold” rating to a “sell” rating in a report on Tuesday, August 15th.

An institutional investor recently bought a new position in eMagin stock. Virtu KCG Holdings LLC bought a new position in shares of eMagin Co. (NYSE:EMAN) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 42,044 shares of the semiconductor company’s stock, valued at approximately $103,000. Virtu KCG Holdings LLC owned approximately 0.13% of eMagin at the end of the most recent quarter.

WARNING: This report was reported by Watch List News and is the property of of Watch List News. If you are accessing this report on another publication, it was illegally copied and republished in violation of international trademark & copyright laws. The original version of this report can be viewed at

eMagin (EMAN) opened at 2.25 on Friday. The company’s 50-day moving average is $2.14 and its 200 day moving average is $2.37. eMagin has a 1-year low of $1.85 and a 1-year high of $3.00. The firm’s market capitalization is $78.69 million.

eMagin Company Profile

eMagin Corporation is engaged in the manufacture of microdisplays using organic light emitting diode (OLED) technology. The Company designs, develops, manufactures and markets OLED on silicon microdisplays, virtual imaging products that utilizes OLED microdisplays and related products. The Company also performs research in the OLED field.

Get a free copy of the Zacks research report on eMagin (EMAN)

For more information about research offerings from Zacks Investment Research, visit

Receive News & Ratings for eMagin Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for eMagin Co. and related companies with Analyst Ratings Network's FREE daily email newsletter.